JBJaimanti Bakshi

Jaimanti Bakshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jaimanti Bakshi has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Quality of Life in Head and Neck Cancer: An EORTC-QLQ-H&N35 Based Assessment

    by Jyoti Saini, Jaimanti Bakshi, Kiran Kumar, Adel Mohammad K. Alrwuili, Naresh K. Panda, Maryada Sharma, Dharam Vir, Atul Kumar Goyal

    Background Head and neck cancer is among the most prevalent cancers in India that impart significant physical and psychological morbidity in patients. The physical symptoms and psychological stress tend to impair the quality of life (QoL) of patients, which in turn affects the survival outcomes. Objective In the present study, we analyze the QoL of head and neck cancer patients using the EORTC-QLQ-H&N35 instrument so that an effective strategy to manage the QoL could be employed to improve treatment and survival outcomes. Methodology Total 205 head and neck cancer patients were included in the study and Hindi version of EORTC-QLQ-H&N35 was used to assessed the QoL. We analyze the QoL according to the sociodemographic factors and clinical determinants. QoL was analyzed according to various scales and subscales of EORTC-QLQ-H&N35. Results The mean global QoL score was 60.08 ± 19.06. QoL did not show any significant difference between the male (60.08 ± 19.06) and female (60.33 ± 19.31) gender. QoL was found to be significantly impaired at the advanced stages of the disease (56.02 ± 20.59). QoL was found to be significantly impaired in oral cancer patients (58.18 ± 19.70) compared to maxillary (66.66 ± 16.66) and larynx cancer (68.18 ± 13.41). In the context of the tumor site, QoL was most impaired in patients with tumors in the mandible region (38.88 ± 25.09). As per the addiction history among patients, the QoL does not show a significant difference among patients in terms of addiction history. Symptoms including nausea, vomiting, constipation and diarrhea are most commonly found to affect the QoL. All of the other factors including pain, less sexuality, mouth opening, dry mouth, sticky saliva were also found to affect the QoL. A higher use of painkillers (74.1%) and nutritional supplements (63.4%) was also observed among patients. Conclusion EORTC-QLQ-H&N35 is the most reliable instrument for assessing the QoL among head and neck cancer patients. The present study indicates that QoL was impaired significantly in head and neck cancer patients and needs to be addressed in treatment protocols.


  • A Prospective Study on Analysis of Voice Quality in Head and Neck Cancer Patients

    by Jyoti Saini, Jaimanti Bakshi, Naresh K. Panda, Maryada Sharma, Dharam Vir, Ahmad K. Alnemare, Turki Bin Mahfoz, Atul Kumar Goyal

    Background Voice is the critical component of communication, and impairment in voice quality tends to affect the overall health status of an individual. Voice quality tends to impair significantly in head and neck cancer patients because the tumors are usually present near the structures which were responsible for the production of voice. Objective The present study aimed to analyze the voice quality in head and neck cancer patients using three instruments including VHI, EORTC-QLQ-H&N35 and SSS. The objective of the study includes analysis of voice quality impairment in different domains including functional, physical, emotional impairment. We also aim to correlate the impartment in voice quality with the gender, cancer stage and site of the tumor. At last, our objective was to analyze the correlation of VHI with the EORTC-QLQ-H&N35 and SSS. Methods Totally, 205 adult head and neck cancer patients were recruited from the outpatient department. Sociodemographic and clinical data were collected using a predesigned proforma. Voice quality among patients was analyzed using the Hindi version of the VHI, EORTC-QLQ-H&N35 and SSS. Results The mean age of 205 patients was 52.79 ± 13.11 years, with a male predominance. Majority of patients presented with stage IV cancer. The most common cancer site was the oral cavity, including the tongue, buccal mucosa and alveolus. The functional and physical states of voice were found to be affected more than the emotional state among all patients. Voice quality was affected more in males compared to the female. Patients with the advanced stage of cancer have more impaired voices. Patients having cancer in the tongue, buccal mucosa, alveolus, larynx and palate tend to have more severely impaired voice quality. A strong correlation of VHI was observed with the SSS and EORTC-QLQ-HN35. Conclusion Voice quality was found to impair at a severe level in head and neck cancer patients. Further studies are required to validate the findings of this study to design treatment protocol that take voice quality of head and neck under consideration.


  • Prevalence, Incidence, and Mortality Trends of Head and Neck Cancers in India: A GLOBOCAN 2022 Statistics Analysis

    by Atul Kumar Goyal, Jyoti Saini, Jaimanti Bakshi, Ahmad K. Alnemare, Turki Bin Mahfoz

    Head and neck cancer is one of the most common cancers worldwide which exhibits a continuous rising trend of prevalence and incidence rates across the globe. Head and neck cancer is found to be more prevalent in developing nations like India where it is responsible for significant cancer-related mortality rate. We aim to analyze the prevalence, incidence, and mortality trends of head and neck cancers in India as per the latest Global Cancer Observatory (GLOBOCAN) 2022 estimates produced by the International Agency for Research on Cancer (IARC) and disseminated as Cancer Today on GLOBOCAN website. The GLOBOCAN 2022 database includes seven types of head and neck cancers, including the lip and oral cavity, hypopharynx, nasopharynx, oropharynx, salivary gland, larynx, and thyroid cancer. These categories are made according to the International Classification of Diseases Related Health Problems, 10th Revision (ICD-10) based on anatomical location of tumor. The data was extracted for the prevalence, incidence, and mortality rate. The incidence rate trend was analyzed for 15 years, from 2003 to 2017. The estimated rise in the incidence rate was predicted until 2050. The highest prevalence was reported for lip and oral cavity cancer which was 26.31, 17.07, and 6.4 for the 5 years, 3 years, and 1 year per 100,000 individuals respectively. The age-standardized rate (ASR) and crude incidence rate were highest for the lip and oral cavity cancers (9.91 and 10.22 respectively). The incidence rate of larynx and thyroid cancer remains stabilized over 15 years from year 2003 to 2017. The percent risk of rise of new cancer cases by the year 2050 is maximum for oropharynx cancer (103.9%). GLOBOCAN is one of most compressive global cancer databases which provides important insight regarding cancer across 185 countries. Head and neck cancer in India was found to impose a high prevalence, incidence, and mortality rate. Healthcare agencies need to derive an action plan to reduce the rising risk of head and neck cancer in India.


  • Classification of Numerical Score of Shame and Stigma Scale for Head and Neck Cancer into the Discrete Categories

    by Atul Kumar Goyal, Jaimanti Bakshi, Jyoti Saini, Ahmad K. Alnemare, Turki Bin Mahfoz

    The shame and stigma scale was developed to specifically analyze the shame and stigma in head and neck cancer patients. However, being a numerical rating scale, it gives a continuous number for each patient, which is difficult for clinicians to interpret. The present study aimed to classify the numerical rating score of the shame and stigma scale into the discrete categories of normal, mild, moderate, and severe. Data from 197 patients with head and neck cancer was obtained using the shame and stigma scale. The shame and stigma scale has a global score and four domains, with a high score representing a high rate of shame and stigma. The numerical score was used to create classification schemes to derive the optimum cutoff points for discrete categories. The variability of the optimal classification scheme was quantified using a bootstrap resampling procedure by repeating the patient sample a thousand times. The classification scheme with the highest F value in ANOVA was used to assign a cutoff to classify the numerical score into normal, mild, moderate, and severe categories. Seven classification schemes were created for global score, appearance domain and stigma domain. Five classification schemes were created for the regret domain, and three classification schemes were created for the speech domain. The optimum cutoff values for global score were 0–10 (normal), 11–30 (mild), 31–50 (moderate) and 51–80 (severe) (F = 1044.105); cutoff values for appearance domain were 0–6 (normal), 7–14 (mild), 15–22 (moderate) and 23–32 (severe) (F = 1344.50); cutoff values for stigma domain were 0–2 (normal), 3–7 (mild), 8–12 (moderate) and 13–20 (severe) (F = 1590.94); cutoff values for regret domain were 0–2 (normal), 3–6 (mild), 7–10 (moderate) and 11–16 (severe) (F = 924.03); and cutoff values for speech domain were 0–2 (normal), 3–5 (mild), 6–8 (moderate) and 9–12 (severe) (F = 1008.38). The present study classifies the numerical rating score of the shame and stigma scale into discrete categories i.e. normal, mild, moderate, and severe by obtaining the optimum cutoff points as per maximum F value. Clinicians can use these cutoff values to classify shame and stigma numerical scores as normal, mild, moderate, and severe for easy interpretation.


  • Matrix Metalloproteinases (MMPs) as Novel Prognostic Biomarkers to Predict Disease Progression, Survival Duration, and Recurrence Rate in Oral Cancer Patients

    by Jyoti Saini, Jaimanti Bakshi, Naresh K. Panda, Maryada Sharma, Dharam Vir, Ahmad K. Alnemare, Turki Bin Mahfoz, Atul Kumar Goyal

    Oral cancer is the most common subtype of head and neck cancer, occupying a large proportion of all cancer patients in India. Since it is a non-communicable disease, it does not spread from person to person. The root of oral cancer development lies in the risk factors responsible for the disease. Addiction to tobacco and alcohol are the primary risk factors, followed by genetic and environmental factors. The gold standard treatment option for oral cancer includes the surgical excision of the tumor following the flap reconstruction for functional rehabilitation. Apart from this, help of radiotherapy, chemotherapy, and immunotherapy could be taken depending upon the disease condition. When patients get affected with the disease and visit the hospital, the primary concern of patients involves the course of disease progression, survival duration after the treatment, and the chance of recurrence of the disease. Despite advancements in medical technology, it is still not possible to predict the progression of disease, survival duration, and recurrence rate in oral cancer. Matrix metalloproteinases (MMPs) are novel biomarkers belonging to the family of the proteinases and are known to be involved in the degradation of the extracellular matrix (ECM). MMPs could be good predictors of disease progression, survival duration, and recurrence rate as the molecular changes appear in the body before the physical changes. By predicting the disease progression, survival duration, and recurrence rate of patients, it will become easy to manage the disease and improve the quality of life of the patients. MMPs can facilitate the regular monitoring of patients for changes in the tumor microenvironment, which can help monitor metastasis. In this review, we highlighted the various types of MMPs and their role in oral cancer. We also aim to integrate all the MMP data into a single molecular pathway so that scattered data can be observed as a useful information tool for further research.


  • Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer Patients on Enzyme-Linked Immunosorbent Assay (ELISA) as Compared to Immunohistochemistry (IHC)

    by Jyoti Saini, Jaimanti Bakshi, Naresh Kumar Panda, Maryada Sharma, Ashok Kumar Yadav, Suruthy Narayansami, Atul Kumar Goyal

    Oral cancer is one of most common noncommunicable diseases that imposed significant burden on healthcare around the globe including India. Several molecular markers have been extensively researched for their potential as diagnostic and prognostic biomarkers for oral cancer. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) found to play a crucial role in cytoskeleton dynamics and thus tumor growth and metastasis. The present study aims to analyze the MMP (MMP-1, MMP-3, MMP-9, and MMP-13) and TIMP (TIMP-1 and TIMP-3) expression in the oral cancer patients as compared to healthy controls. We also aim to compare the diagnostic accuracy of MMPs and TIMPs on enzyme-linked immunosorbent assay (ELISA) with respect to the immunohistochemistry (IHC). A total of 15 oral cancer patients and 14 healthy controls were enrolled in this study. Blood sample from oral cancer patients and healthy controls was obtained to analyze the MMP and TIMP expression levels in serum sample using ELISA. Tumor tissue sample from patients for IHC analysis was obtained by biopsy under local anesthesia. Data were compared between ELISA and IHC for sensitivity and specificity analysis. The mean age of the patients was 47.07 ± 15.74 years with the highest incidence of disease found in male gender (86.7%). MMPs and TIMPs exhibited higher expression in oral cancer patients as compared to healthy controls and the difference was statistically significant in case of MMP-13. MMPs and TIMPs showed stronger expression at advanced stages of cancer on IHC with MMP-9 exhibiting the highest expression level. The highest sensitivity and specificity on ELISA with respect to IHC were exhibited by the MMP-3 followed by MMP-13, TIMP-1, TIMP-3, and MMP-1. MMP-3 and MMP-13 were found to be reliable in terms of diagnostic marker for oral cancer as they found to have the highest sensitivity and specificity on ELISA with respect to IHC. MMP-9 was found to be reliable as a prognostic marker as it expresses highest on IHC at advanced stages of oral cancer.


  • Open Access

    F-18 FDG PET/CT Versus RAI-WBS and Neck USG in Early Diagnosis of Recurrent Differentiated Thyroid Cancer

    by Jaimanti Bakshi, Naresh K. Panda, Atul Kumar Goyal, Jyoti Saini, Sovit Jung Baral, Bhagwant Rai Mittal, Anupam Lal

    Background: Differentiated thyroid cancer (DTC) contributes up to 90% of total thyroid malignancies, and due to chances of high recurrence chances, postoperative surveillance is performed by regular clinical follow-ups using routine neck ultrasonography (USG) and radioactive iodine whole-body scan (RAI-WBS). Objectives: Positron emission tomography and computed tomography (F-18 FDG PET/CT) has emerged as promising techniques for the early detection of many malignancies, and therefore this study aims to analyse the effectiveness of F-18 FDG PET/CT vs. RAI-WBS and neck USG in early diagnosis of recurrence in DTC after thyroidectomy. Materials and Methods: For this, a total of 30 patients diagnosed with the DTC were recruited in the study and were followed-up for the assessment of recurrence of the disease. Either F-18 FDG PET/CT or RAI-WBS and neck USG was used as a recurrence assessment tool, and data were compared for the sensitivity and specificity of the tool. Results: The recurrence rate was found to be 26.67%. F-18 FDG PET/CT exhibited a significant advantage over RAI-WBS and neck USG for early detection of recurrence of DTC. F-18 FDG PET/CT was found to exhibit good sensitivity and high specificity compared to the RAI-WBS and neck USG for early detection of recurrence of DTC. Conclusion: F-18 FDG PET/CT is recommended to be used in those cases which have a high suspicion of DTC recurrence but is marked negative in other imaging techniques.

  • Open Access

    Pretreatment Trismus as a Predictor of Survival Outcome in Oral Cancer Patients

    by Jaimanti Bakshi, Naresh K. Panda, Atul Kumar Goyal, Jyoti Saini, Shivji Prashant, Ganesh Aggarwal, Ahmad K. Alnemare

    Background: Trismus is the restricted mouth opening (≤35 mm) in oral cancer patients that may occurred due to the limited stretching of facial muscles because of tumor growth. Trismus can significantly affect the uptake and chewing of food which in turn cause nutrition depletion in cancer patients, thus affecting their quality of life and survival outcomes. Objectives: The present study was aimed to analyze the role of pretreatment trismus as a predictor of survival outcomes, including long-term survival and disease-free survival in oral cancer patients. Materials and Methods: A total of 38 oral cancer patients with restricted mouth opening were enrolled in the study. The trismus was assessed before the surgery using digital vernier caliper. The patients were then follow-up for survival outcomes over the period of 5 years. The survival outcomes were then correlated with the pretreatment trismus. Results: Poor long-term and disease-free survivals were found to be significantly associated with the high-grade pretreatment trismus. Patients with high grades of pretreatment trismus experienced early treatment relapse and high mortality. Conclusions: Pretreatment trismus was found to be a potential predictor of disease-free survival and overall long-term survival in oral cancer patients. It is recommended that a treatment protocol that could reduce the trismus should be adopted to enhance the survival outcomes of oral cancer patients.